APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metabotropic Glutamate Receptor 5

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Metabotropic Glutamate Receptor 5 Industry Growth and Trends Forecast to 2032

22 December 2025102 pages

Choose your research edition.

Industry ResearchMetabotropic Glutamate Receptor 5 Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Metabotropic Glutamate Receptor 5 Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Metabotropic Glutamate Receptor 5 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metabotropic Glutamate Receptor 5 Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Metabotropic Glutamate Receptor 5 Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Metabotropic Glutamate Receptor 5 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Metabotropic Glutamate Receptor 5 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Metabotropic Glutamate Receptor 5 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Metabotropic Glutamate Receptor 5 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Metabotropic Glutamate Receptor 5 include Addex Therapeutics Ltd, Aevi Genomic Medicine Inc, Bristol-Myers Squibb Company, Heptares Therapeutics Ltd, Merz Pharma GmbH & Co KgaA, Richter Gedeon Nyrt, Sumitomo Dainippon Pharma Co Ltd, Toray Industries Inc and Eli Lilly and Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Metabotropic Glutamate Receptor 5 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Metabotropic Glutamate Receptor 5 market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Metabotropic Glutamate Receptor 5 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Metabotropic Glutamate Receptor 5.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Metabotropic Glutamate Receptor 5 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Metabotropic Glutamate Receptor 5 Market by Company

Addex Therapeutics Ltd

Aevi Genomic Medicine Inc

Bristol-Myers Squibb Company

Heptares Therapeutics Ltd

Merz Pharma GmbH & Co KgaA

Richter Gedeon Nyrt

Sumitomo Dainippon Pharma Co Ltd

Toray Industries Inc

Eli Lilly and Company

Novartis AG

Johnson & Johnson

Eisai Co Ltd

Metabotropic Glutamate Receptor 5 Segment by Type

Alloswitch-1

BMS-952048

BMS-955829

Dipraglurant ER

Others

Metabotropic Glutamate Receptor 5 Segment by Application

Major Depressive Disorder

Alcohol Addiction

Alzheimer's Disease

Others

Metabotropic Glutamate Receptor 5 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metabotropic Glutamate Receptor 5 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metabotropic Glutamate Receptor 5 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metabotropic Glutamate Receptor 5.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Metabotropic Glutamate Receptor 5 manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Metabotropic Glutamate Receptor 5 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Alloswitch-1 Table 2. Major Company of BMS-952048 Table 3. Major Company of BMS-955829 Table 4. Major Company of Dipraglurant ER Table 5. Major Company of Others Table 6. Global Metabotropic Glutamate Receptor 5 Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (k units) Table 8. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Type (2021-2026) Table 9. Global Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (US$ Million) Table 10. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Type (2021-2026) Table 11. Global Metabotropic Glutamate Receptor 5 Price by Type (2021-2026) & (US$/unit) Table 12. Global Metabotropic Glutamate Receptor 5 Sales by Type (2027-2032) & (k units) Table 13. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Type (2027-2032) Table 14. Global Metabotropic Glutamate Receptor 5 Sales by Type (2027-2032) & (US$ Million) Table 15. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Type (2027-2032) Table 16. Global Metabotropic Glutamate Receptor 5 Price by Type (2027-2032) & (US$/unit) Table 17. North America Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (k units) Table 18. North America Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (k units) Table 20. Europe Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (k units) Table 22. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (k units) Table 24. Latin America Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (k units) Table 26. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Type (2021-2026) & (US$ Million) Table 27. Metabotropic Glutamate Receptor 5 Industry Trends Table 28. Metabotropic Glutamate Receptor 5 Industry Drivers Table 29. Metabotropic Glutamate Receptor 5 Industry Opportunities and Challenges Table 30. Metabotropic Glutamate Receptor 5 Industry Restraints Table 31. Global Metabotropic Glutamate Receptor 5 Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Company (2021-2026) Table 33. Global Metabotropic Glutamate Receptor 5 Sales by Company (2021-2026) & (k units) Table 34. Global Metabotropic Glutamate Receptor 5 Sales Share by Company (2021-2026) Table 35. Global Metabotropic Glutamate Receptor 5 Market Price by Company (2021-2026) & (US$/unit) Table 36. Global Metabotropic Glutamate Receptor 5 Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Metabotropic Glutamate Receptor 5 Major Company Production Sites and Headquarters Table 38. Global Metabotropic Glutamate Receptor 5 Company, Product Type & Application Table 39. Global Metabotropic Glutamate Receptor 5 Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Metabotropic Glutamate Receptor 5 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Metabotropic Glutamate Receptor 5 Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Metabotropic Glutamate Receptor 5 Sales by Region (2021-2026) & (k units) Table 44. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Region (2021-2026) Table 45. Global Metabotropic Glutamate Receptor 5 Sales by Region (2021-2026) & (US$ Million) Table 46. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Region (2021-2026) Table 47. Global Metabotropic Glutamate Receptor 5 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 48. Global Metabotropic Glutamate Receptor 5 Sales by Region (2027-2032) & (k units) Table 49. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Region (2027-2032) Table 50. Global Metabotropic Glutamate Receptor 5 Sales by Region (2027-2032) & (US$ Million) Table 51. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Region (2027-2032) Table 52. Global Metabotropic Glutamate Receptor 5 Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 53. Global Metabotropic Glutamate Receptor 5 Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (k units) Table 55. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Application (2021-2026) Table 56. Global Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (US$ Million) Table 57. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Application (2021-2026) Table 58. Global Metabotropic Glutamate Receptor 5 Price by Application (2021-2026) & (US$/unit) Table 59. Global Metabotropic Glutamate Receptor 5 Sales by Application (2027-2032) & (k units) Table 60. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Application (2027-2032) Table 61. Global Metabotropic Glutamate Receptor 5 Sales by Application (2027-2032) & (US$ Million) Table 62. Global Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Application (2027-2032) Table 63. Global Metabotropic Glutamate Receptor 5 Price by Application (2027-2032) & (US$/unit) Table 64. North America Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (k units) Table 65. North America Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (k units) Table 67. Europe Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (k units) Table 69. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (k units) Table 71. Latin America Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (k units) Table 73. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Application (2021-2026) & (US$ Million) Table 74. Addex Therapeutics Ltd Company Information Table 75. Addex Therapeutics Ltd Business Overview Table 76. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Portfolio Table 78. Addex Therapeutics Ltd Recent Development Table 79. Aevi Genomic Medicine Inc Company Information Table 80. Aevi Genomic Medicine Inc Business Overview Table 81. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product Portfolio Table 83. Aevi Genomic Medicine Inc Recent Development Table 84. Bristol-Myers Squibb Company Company Information Table 85. Bristol-Myers Squibb Company Business Overview Table 86. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product Portfolio Table 88. Bristol-Myers Squibb Company Recent Development Table 89. Heptares Therapeutics Ltd Company Information Table 90. Heptares Therapeutics Ltd Business Overview Table 91. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Portfolio Table 93. Heptares Therapeutics Ltd Recent Development Table 94. Merz Pharma GmbH & Co KgaA Company Information Table 95. Merz Pharma GmbH & Co KgaA Business Overview Table 96. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product Portfolio Table 98. Merz Pharma GmbH & Co KgaA Recent Development Table 99. Richter Gedeon Nyrt Company Information Table 100. Richter Gedeon Nyrt Business Overview Table 101. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product Portfolio Table 103. Richter Gedeon Nyrt Recent Development Table 104. Sumitomo Dainippon Pharma Co Ltd Company Information Table 105. Sumitomo Dainippon Pharma Co Ltd Business Overview Table 106. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product Portfolio Table 108. Sumitomo Dainippon Pharma Co Ltd Recent Development Table 109. Toray Industries Inc Company Information Table 110. Toray Industries Inc Business Overview Table 111. Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Toray Industries Inc Metabotropic Glutamate Receptor 5 Product Portfolio Table 113. Toray Industries Inc Recent Development Table 114. Eli Lilly and Company Company Information Table 115. Eli Lilly and Company Business Overview Table 116. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product Portfolio Table 118. Eli Lilly and Company Recent Development Table 119. Novartis AG Company Information Table 120. Novartis AG Business Overview Table 121. Novartis AG Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Novartis AG Metabotropic Glutamate Receptor 5 Product Portfolio Table 123. Novartis AG Recent Development Table 124. Johnson & Johnson Company Information Table 125. Johnson & Johnson Business Overview Table 126. Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Johnson & Johnson Metabotropic Glutamate Receptor 5 Product Portfolio Table 128. Johnson & Johnson Recent Development Table 129. Eisai Co Ltd Company Information Table 130. Eisai Co Ltd Business Overview Table 131. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product Portfolio Table 133. Eisai Co Ltd Recent Development Table 134. North America Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 135. North America Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (k units) Table 136. North America Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2021-2026) Table 137. North America Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2027-2032) & (k units) Table 138. North America Metabotropic Glutamate Receptor 5 Sales Market Share Forecast by Country (2027-2032) Table 139. North America Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 140. North America Metabotropic Glutamate Receptor 5 Market Size by Country (2021-2026) & (US$ Million) Table 141. North America Metabotropic Glutamate Receptor 5 Market Share by Country (2021-2026) Table 142. North America Metabotropic Glutamate Receptor 5 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 143. North America Metabotropic Glutamate Receptor 5 Market Share Forecast by Country (2027-2032) Table 144. Europe Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 145. Europe Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (k units) Table 146. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2021-2026) Table 147. Europe Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2027-2032) & (k units) Table 148. Europe Metabotropic Glutamate Receptor 5 Sales Market Share Forecast by Country (2027-2032) Table 149. Europe Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 150. Europe Metabotropic Glutamate Receptor 5 Market Size by Country (2021-2026) & (US$ Million) Table 151. Europe Metabotropic Glutamate Receptor 5 Market Share by Country (2021-2026) Table 152. Europe Metabotropic Glutamate Receptor 5 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 153. Europe Metabotropic Glutamate Receptor 5 Market Share Forecast by Country (2027-2032) Table 154. Asia-Pacific Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 155. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (k units) Table 156. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2021-2026) Table 157. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2027-2032) & (k units) Table 158. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Market Share Forecast by Country (2027-2032) Table 159. Asia-Pacific Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 160. Asia-Pacific Metabotropic Glutamate Receptor 5 Market Size by Country (2021-2026) & (US$ Million) Table 161. Asia-Pacific Metabotropic Glutamate Receptor 5 Market Share by Country (2021-2026) Table 162. Asia-Pacific Metabotropic Glutamate Receptor 5 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 163. Asia-Pacific Metabotropic Glutamate Receptor 5 Market Share Forecast by Country (2027-2032) Table 164. Latin America Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 165. Latin America Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (k units) Table 166. Latin America Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2021-2026) Table 167. Latin America Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2027-2032) & (k units) Table 168. Latin America Metabotropic Glutamate Receptor 5 Sales Market Share Forecast by Country (2027-2032) Table 169. Latin America Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 170. Latin America Metabotropic Glutamate Receptor 5 Market Size by Country (2021-2026) & (US$ Million) Table 171. Latin America Metabotropic Glutamate Receptor 5 Market Share by Country (2021-2026) Table 172. Latin America Metabotropic Glutamate Receptor 5 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 173. Latin America Metabotropic Glutamate Receptor 5 Market Share Forecast by Country (2027-2032) Table 174. Middle East and Africa Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 175. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026) & (k units) Table 176. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2021-2026) Table 177. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2027-2032) & (k units) Table 178. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Market Share Forecast by Country (2027-2032) Table 179. Middle East and Africa Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 180. Middle East and Africa Metabotropic Glutamate Receptor 5 Market Size by Country (2021-2026) & (US$ Million) Table 181. Middle East and Africa Metabotropic Glutamate Receptor 5 Market Share by Country (2021-2026) Table 182. Middle East and Africa Metabotropic Glutamate Receptor 5 Market Size Forecast by Country (2027-2032) & (US$ Million) Table 183. Middle East and Africa Metabotropic Glutamate Receptor 5 Market Share Forecast by Country (2027-2032) Table 184. Key Raw Materials Table 185. Raw Materials Key Suppliers Table 186. Metabotropic Glutamate Receptor 5 Distributors List Table 187. Metabotropic Glutamate Receptor 5 Customers List Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. Metabotropic Glutamate Receptor 5 Image Figure 2. Global Metabotropic Glutamate Receptor 5 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metabotropic Glutamate Receptor 5 Market Size (2021-2032) & (US$ Million) Figure 4. Global Metabotropic Glutamate Receptor 5 Sales (2021-2032) & (k units) Figure 5. Alloswitch-1 Image Figure 6. Global Alloswitch-1 Sales YoY Growth (2021-2032) & (k units) Figure 7. BMS-952048 Image Figure 8. Global BMS-952048 Sales YoY Growth (2021-2032) & (k units) Figure 9. BMS-955829 Image Figure 10. Global BMS-955829 Sales YoY Growth (2021-2032) & (k units) Figure 11. Dipraglurant ER Image Figure 12. Global Dipraglurant ER Sales YoY Growth (2021-2032) & (k units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 15. Global Metabotropic Glutamate Receptor 5 Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Metabotropic Glutamate Receptor 5 Market Share by Type 2025 VS 2032 Figure 17. North America Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Type in 2025 Figure 18. North America Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Type in 2025 Figure 19. Europe Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Type in 2025 Figure 20. Europe Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Type in 2025 Figure 23. Latin America Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Metabotropic Glutamate Receptor 5 Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Major Depressive Disorder Image Figure 30. Global Major Depressive Disorder Sales YoY Growth (2021-2032) & (k units) Figure 31. Alcohol Addiction Image Figure 32. Global Alcohol Addiction Sales YoY Growth (2021-2032) & (k units) Figure 33. Alzheimer's Disease Image Figure 34. Global Alzheimer's Disease Sales YoY Growth (2021-2032) & (k units) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 37. Global Metabotropic Glutamate Receptor 5 Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Metabotropic Glutamate Receptor 5 Market Share by Application 2025 VS 2032 Figure 39. North America Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Application in 2025 Figure 40. North America Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Application in 2025 Figure 41. Europe Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Application in 2025 Figure 42. Europe Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Application in 2025 Figure 45. Latin America Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Market Share in Value by Application in 2025 Figure 49. North America Metabotropic Glutamate Receptor 5 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. North America Metabotropic Glutamate Receptor 5 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Metabotropic Glutamate Receptor 5 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Metabotropic Glutamate Receptor 5 Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Metabotropic Glutamate Receptor 5 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Europe Metabotropic Glutamate Receptor 5 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Metabotropic Glutamate Receptor 5 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Metabotropic Glutamate Receptor 5 Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Metabotropic Glutamate Receptor 5 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Metabotropic Glutamate Receptor 5 Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Metabotropic Glutamate Receptor 5 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Latin America Metabotropic Glutamate Receptor 5 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Metabotropic Glutamate Receptor 5 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Metabotropic Glutamate Receptor 5 Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Metabotropic Glutamate Receptor 5 Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Metabotropic Glutamate Receptor 5 Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Metabotropic Glutamate Receptor 5 Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Metabotropic Glutamate Receptor 5 Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Alloswitch-1
  • BMS-952048
  • BMS-955829
  • Dipraglurant ER
  • Others
Applications
  • Major Depressive Disorder
  • Alcohol Addiction
  • Alzheimer's Disease
  • Others
Companies covered
  • Addex Therapeutics Ltd
  • Aevi Genomic Medicine Inc
  • Bristol-Myers Squibb Company
  • Heptares Therapeutics Ltd
  • Merz Pharma GmbH & Co KgaA
  • Richter Gedeon Nyrt
  • Sumitomo Dainippon Pharma Co Ltd
  • Toray Industries Inc
  • Eli Lilly and Company
  • Novartis AG
  • Johnson & Johnson
  • Eisai Co Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Metabotropic Glutamate Receptor 5 Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Metabotropic Glutamate Receptor 5 Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Metabotropic Glutamate Receptor 5 Market by Type
  6. 1.3.1 Alloswitch-1
  7. 1.3.2 BMS-952048
  8. 1.3.3 BMS-955829
  9. 1.3.4 Dipraglurant ER
  10. 1.3.5 Others
  11. 1.4 Global Metabotropic Glutamate Receptor 5 Market Size by Type
  12. 1.4.1 Global Metabotropic Glutamate Receptor 5 Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Metabotropic Glutamate Receptor 5 Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Metabotropic Glutamate Receptor 5 Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Metabotropic Glutamate Receptor 5 Industry Trends
  2. 2.2 Metabotropic Glutamate Receptor 5 Industry Drivers
  3. 2.3 Metabotropic Glutamate Receptor 5 Industry Opportunities and Challenges
  4. 2.4 Metabotropic Glutamate Receptor 5 Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Metabotropic Glutamate Receptor 5 Revenue (2021-2026)
  2. 3.2 Global Top Players by Metabotropic Glutamate Receptor 5 Sales (2021-2026)
  3. 3.3 Global Top Players by Metabotropic Glutamate Receptor 5 Price (2021-2026)
  4. 3.4 Global Metabotropic Glutamate Receptor 5 Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Metabotropic Glutamate Receptor 5 Major Company Production Sites & Headquarters
  6. 3.6 Global Metabotropic Glutamate Receptor 5 Company, Product Type & Application
  7. 3.7 Global Metabotropic Glutamate Receptor 5 Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Metabotropic Glutamate Receptor 5 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Metabotropic Glutamate Receptor 5 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Metabotropic Glutamate Receptor 5 Tier 1, Tier 2, and Tier 3
4 Metabotropic Glutamate Receptor 5 Regional Status and Outlook
  1. 4.1 Global Metabotropic Glutamate Receptor 5 Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Metabotropic Glutamate Receptor 5 Historic Market Size by Region
  3. 4.2.1 Global Metabotropic Glutamate Receptor 5 Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Metabotropic Glutamate Receptor 5 Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Metabotropic Glutamate Receptor 5 Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Metabotropic Glutamate Receptor 5 Forecasted Market Size by Region
  7. 4.3.1 Global Metabotropic Glutamate Receptor 5 Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Metabotropic Glutamate Receptor 5 Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Metabotropic Glutamate Receptor 5 Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Metabotropic Glutamate Receptor 5 by Application
  1. 5.1 Metabotropic Glutamate Receptor 5 Market by Application
  2. 5.1.1 Major Depressive Disorder
  3. 5.1.2 Alcohol Addiction
  4. 5.1.3 Alzheimer's Disease
  5. 5.1.4 Others
  6. 5.2 Global Metabotropic Glutamate Receptor 5 Market Size by Application
  7. 5.2.1 Global Metabotropic Glutamate Receptor 5 Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Metabotropic Glutamate Receptor 5 Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Metabotropic Glutamate Receptor 5 Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Metabotropic Glutamate Receptor 5 Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Metabotropic Glutamate Receptor 5 Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Metabotropic Glutamate Receptor 5 Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Addex Therapeutics Ltd
  2. 6.1.1 Addex Therapeutics Ltd Company Information
  3. 6.1.2 Addex Therapeutics Ltd Business Overview
  4. 6.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Portfolio
  6. 6.1.5 Addex Therapeutics Ltd Recent Developments
  7. 6.2 Aevi Genomic Medicine Inc
  8. 6.2.1 Aevi Genomic Medicine Inc Company Information
  9. 6.2.2 Aevi Genomic Medicine Inc Business Overview
  10. 6.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product Portfolio
  12. 6.2.5 Aevi Genomic Medicine Inc Recent Developments
  13. 6.3 Bristol-Myers Squibb Company
  14. 6.3.1 Bristol-Myers Squibb Company Company Information
  15. 6.3.2 Bristol-Myers Squibb Company Business Overview
  16. 6.3.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product Portfolio
  18. 6.3.5 Bristol-Myers Squibb Company Recent Developments
  19. 6.4 Heptares Therapeutics Ltd
  20. 6.4.1 Heptares Therapeutics Ltd Company Information
  21. 6.4.2 Heptares Therapeutics Ltd Business Overview
  22. 6.4.3 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Portfolio
  24. 6.4.5 Heptares Therapeutics Ltd Recent Developments
  25. 6.5 Merz Pharma GmbH & Co KgaA
  26. 6.5.1 Merz Pharma GmbH & Co KgaA Company Information
  27. 6.5.2 Merz Pharma GmbH & Co KgaA Business Overview
  28. 6.5.3 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product Portfolio
  30. 6.5.5 Merz Pharma GmbH & Co KgaA Recent Developments
  31. 6.6 Richter Gedeon Nyrt
  32. 6.6.1 Richter Gedeon Nyrt Company Information
  33. 6.6.2 Richter Gedeon Nyrt Business Overview
  34. 6.6.3 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product Portfolio
  36. 6.6.5 Richter Gedeon Nyrt Recent Developments
  37. 6.7 Sumitomo Dainippon Pharma Co Ltd
  38. 6.7.1 Sumitomo Dainippon Pharma Co Ltd Company Information
  39. 6.7.2 Sumitomo Dainippon Pharma Co Ltd Business Overview
  40. 6.7.3 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product Portfolio
  42. 6.7.5 Sumitomo Dainippon Pharma Co Ltd Recent Developments
  43. 6.8 Toray Industries Inc
  44. 6.8.1 Toray Industries Inc Company Information
  45. 6.8.2 Toray Industries Inc Business Overview
  46. 6.8.3 Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Toray Industries Inc Metabotropic Glutamate Receptor 5 Product Portfolio
  48. 6.8.5 Toray Industries Inc Recent Developments
  49. 6.9 Eli Lilly and Company
  50. 6.9.1 Eli Lilly and Company Company Information
  51. 6.9.2 Eli Lilly and Company Business Overview
  52. 6.9.3 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product Portfolio
  54. 6.9.5 Eli Lilly and Company Recent Developments
  55. 6.10 Novartis AG
  56. 6.10.1 Novartis AG Company Information
  57. 6.10.2 Novartis AG Business Overview
  58. 6.10.3 Novartis AG Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Novartis AG Metabotropic Glutamate Receptor 5 Product Portfolio
  60. 6.10.5 Novartis AG Recent Developments
  61. 6.11 Johnson & Johnson
  62. 6.11.1 Johnson & Johnson Company Information
  63. 6.11.2 Johnson & Johnson Business Overview
  64. 6.11.3 Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Johnson & Johnson Metabotropic Glutamate Receptor 5 Product Portfolio
  66. 6.11.5 Johnson & Johnson Recent Developments
  67. 6.12 Eisai Co Ltd
  68. 6.12.1 Eisai Co Ltd Company Information
  69. 6.12.2 Eisai Co Ltd Business Overview
  70. 6.12.3 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product Portfolio
  72. 6.12.5 Eisai Co Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Metabotropic Glutamate Receptor 5 Sales by Country
  2. 7.1.1 North America Metabotropic Glutamate Receptor 5 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026)
  4. 7.1.3 North America Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2027-2032)
  5. 7.2 North America Metabotropic Glutamate Receptor 5 Market Size by Country
  6. 7.2.1 North America Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Metabotropic Glutamate Receptor 5 Market Size by Country (2021-2026)
  8. 7.2.3 North America Metabotropic Glutamate Receptor 5 Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Metabotropic Glutamate Receptor 5 Sales by Country
  2. 8.1.1 Europe Metabotropic Glutamate Receptor 5 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026)
  4. 8.1.3 Europe Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Metabotropic Glutamate Receptor 5 Market Size by Country
  6. 8.2.1 Europe Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Metabotropic Glutamate Receptor 5 Market Size by Country (2021-2026)
  8. 8.2.3 Europe Metabotropic Glutamate Receptor 5 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Country
  2. 9.1.1 Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Metabotropic Glutamate Receptor 5 Market Size by Country
  6. 9.2.1 Asia-Pacific Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Metabotropic Glutamate Receptor 5 Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Metabotropic Glutamate Receptor 5 Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Metabotropic Glutamate Receptor 5 Sales by Country
  2. 10.1.1 South America Metabotropic Glutamate Receptor 5 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026)
  4. 10.1.3 South America Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2027-2032)
  5. 10.2 South America Metabotropic Glutamate Receptor 5 Market Size by Country
  6. 10.2.1 South America Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Metabotropic Glutamate Receptor 5 Market Size by Country (2021-2026)
  8. 10.2.3 South America Metabotropic Glutamate Receptor 5 Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Country
  2. 11.1.1 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Metabotropic Glutamate Receptor 5 Market Size by Country
  6. 11.2.1 Middle East and Africa Metabotropic Glutamate Receptor 5 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Metabotropic Glutamate Receptor 5 Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Metabotropic Glutamate Receptor 5 Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Metabotropic Glutamate Receptor 5 Value Chain Analysis
  2. 12.1.1 Metabotropic Glutamate Receptor 5 Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Metabotropic Glutamate Receptor 5 Production Mode & Process
  7. 12.2 Metabotropic Glutamate Receptor 5 Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Metabotropic Glutamate Receptor 5 Distributors
  10. 12.2.3 Metabotropic Glutamate Receptor 5 Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst